P&G Adds Merck's Brands, Expands Consumer Health Categories, Footprint
Executive Summary
P&G’s planned acquisition of Merck KGaA’s consumer health care business will grow its consumer health portfolio 50%, expand its OTC drug and supplement business abroad and open up new categories. CEO David Taylor frames the acquisition as another step in the firm's ongoing portfolio shakeup.
You may also be interested in...
P&G Raises Guidance On Strong Q1 With Analysts Anticipating Headwinds
Net and organic sales up 7% to $17.8bn in its FY 2020 Q1 as its turnaround takes hold and pricing increases it implemented a year ago push revenues. CFO Jon Moeller says P&G revises guidance upwards for FY2020 and is better positioned to counter potential recession headwinds than it was in 2008.
P&G's Personal Health Sector Has Merck Consumer Chief As International Head
P&G names Merck KGAA consumer chief Uta Kemmerich-Keil to lead international division of personal health business as it closes on $4.2bn acquisition of German firm's consumer business. Deal closes a month after P&G announced biggest changes to organizational structure in 20 years, including combining personal care and health care into personal health and forming six global units, each headed by a CEO.
P&G's Personal Health Sector Has Merck Consumer Chief As International Head
P&G names Merck KGAA consumer chief Uta Kemmerich-Keil to lead international division of personal health business as it closes on $4.2bn acquisition of German firm's consumer business. Deal closes a month after P&G announced biggest changes to organizational structure in 20 years, including combining personal care and health care into personal health and forming six global units, each headed by a CEO.